Regenxbio Inc logo

Regenxbio Inc

1
NAS:RGNX (USA)  
$ 12.58 -0.27 (-2.1%) 10:08 PM EST
At Loss
P/B:
1.58
Market Cap:
$ 619.64M
Enterprise V:
$ 368.19M
Volume:
422.04K
Avg Vol (2M):
608.75K
Trade In:
Volume:
422.04K
At Loss
Avg Vol (2M):
608.75K

Business Description

Description
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 3.88
Equity-to-Asset 0.62
Debt-to-Equity 0.22
Debt-to-EBITDA -0.37
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.8
Distress
Grey
Safe
Beneish M-Score -3.6
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 51.57
9-Day RSI 53.61
14-Day RSI 50.19
6-1 Month Momentum % -10.94
12-1 Month Momentum % -33.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.59
Quick Ratio 3.59
Cash Ratio 3.07
Days Sales Outstanding 4.88
Days Payable 216.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.5
Shareholder Yield % -22.05

Financials (Next Earnings Date:2024-08-02 Est.)

RGNX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RGNX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Regenxbio Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 86.726
EPS (TTM) ($) -5.87
Beta 1.2
Volatility % 90.68
14-Day RSI 50.19
14-Day ATR ($) 0.795835
20-Day SMA ($) 11.9045
12-1 Month Momentum % -33.39
52-Week Range ($) 10.49 - 28.8
Shares Outstanding (Mil) 49.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Regenxbio Inc Filings

Filing Date Document Date Form
No Filing Data

Regenxbio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Regenxbio Inc Frequently Asked Questions

What is Regenxbio Inc(RGNX)'s stock price today?
The current price of RGNX is $12.58. The 52 week high of RGNX is $28.80 and 52 week low is $10.49.
When is next earnings date of Regenxbio Inc(RGNX)?
The next earnings date of Regenxbio Inc(RGNX) is 2024-08-02 Est..
Does Regenxbio Inc(RGNX) pay dividends? If so, how much?
Regenxbio Inc(RGNX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1